Meeting
2016 ASCO Annual Meeting
Immune gene expression, survival outcome and response to PD-1/PD-L1 blockade: a TCGA pan-cancer analysis.
Authors
Elia Seguí
Hospital Clínic de Barcelona. Universitat de Barcelona, Barcelona, Spain
Elia Seguí , Laia Paré , Barbara Adamo , Estela Pineda , Mercedes Marín-Aguilera , Òscar Reig , Javier Garcia Corbacho , Montserrat Munoz , Manel Juan , Victoria Sanchez , Margarita Viladot , Carme Font , Daniel Benitez , Cristina Nadal , Nuria Vinolas , Núria de la Iglesia , Begona Mellado , Juan Maurel , Noemi Reguart , Aleix Prat
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics and Translational Research
Sub Track
Biomarkers and Correlative Studies from Immunotherapy Trials
Citation
J Clin Oncol 34, 2016 (suppl; abstr 3033)
DOI
10.1200/JCO.2016.34.15_suppl.3033
Abstract #
3033
Poster Bd #
355
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Immune-checkpoint genes as predictive biomarkers of trabectedin in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) translational study.
First Author: David Silva Moura
Poster
2016 ASCO Annual Meeting
Analysis of immune infiltrates in a genomically characterized clinical cohort of head and neck squamous cell carcinoma (HNSCC) patients (pts).
First Author: Nicole Grace Chau
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Galectin-9 as a regulator of immune interactions in the tumor microenvironment and novel therapeutic target in biliary tract cancer.
First Author: Emilie AK Warren
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A transcriptomic approach to explore the immune landscape of patient with pancreatic ductal adenocarcinoma with prognostic impact.
First Author: Jose Antonio Lopez Guerrero